Browsing by Author Borrego, Francisco

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
PreviewTitleAuthor(s)Issue Date
Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers.Vitallé, Joana; Terrén, Iñigo; Gamboa-Urquijo, Leire; Orrantia, Ane; Tarancón-Díez, Laura; Genebat, Miguel; Ruiz-Mateos, Ezequiel; Leal, Manuel; García-Obregón, Susana; Zenarruzabeitia, Olatz; Borrego, Francisco23-Jul-2018
Editorial: NK Cell-Based Cancer Immunotherapy.Borrego, Francisco; Larrucea, Susana; Solana, Rafael; Tarazona, Raquel27-Jun-2016
Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression.Vitallé, Joana; Zenarruzabeitia, Olatz; Terrén, Iñigo; Plana, Montserrat; Guardo, Alberto C; Leal, Lorna; Peña, José; García, Felipe; Borrego, Francisco21-Jul-2017
Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300aVitallé, Joana; Terrén, Iñigo; Gamboa-Urquijo, Leire; Orrantia, Ane; Tarancón-Díez, Laura; Genebat, Miguel; Leal, Manuel; Ruiz-Mateos, Ezequiel; Borrego, Francisco; Zenarruzabeitia, Olatz8-Apr-2020
Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a.Vitallé, Joana; Terrén, Iñigo; Gamboa-Urquijo, Leire; Orrantia, Ane; Tarancón-Díez, Laura; Genebat, Miguel; Leal, Manuel; Ruiz-Mateos, Ezequiel; Borrego, Francisco; Zenarruzabeitia, Olatz8-Apr-2020
Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney disease.Naranjo, Javier; Borrego, Francisco; Rocha, José Luis; Salgueira, Mercedes; Martín-Gomez, Maria Adoración; Orellana, Cristhian; Morales, Ana; Vallejo, Fernando; Hidalgo, Pilar; Rodríguez, Francisca; Garófano, Remedios; González, Isabel; Esteban, Rafael; Espinosa, Mario29-Sep-2022